236 related articles for article (PubMed ID: 31825647)
1. Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials.
Quaife SL; Ruparel M; Dickson JL; Beeken RJ; McEwen A; Baldwin DR; Bhowmik A; Navani N; Sennett K; Duffy SW; Wardle J; Waller J; Janes SM
Am J Respir Crit Care Med; 2020 Apr; 201(8):965-975. PubMed ID: 31825647
[No Abstract] [Full Text] [Related]
2. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients.
Quaife SL; Ruparel M; Beeken RJ; McEwen A; Isitt J; Nolan G; Sennett K; Baldwin DR; Duffy SW; Janes SM; Wardle J
BMC Cancer; 2016 Apr; 16():281. PubMed ID: 27098676
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
[No Abstract] [Full Text] [Related]
4. Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT).
Kummer S; Waller J; Ruparel M; Duffy SW; Janes SM; Quaife SL
Thorax; 2020 Dec; 75(12):1065-1073. PubMed ID: 33087548
[TBL] [Abstract][Full Text] [Related]
5. Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study.
Dickson JL; Hall H; Horst C; Tisi S; Verghese P; Mullin AM; Teague J; Farrelly L; Bowyer V; Gyertson K; Bojang F; Levermore C; Anastasiadis T; McCabe J; Navani N; Nair A; Devaraj A; Hackshaw A; Quaife SL; Janes SM;
Lancet Public Health; 2023 Feb; 8(2):e130-e140. PubMed ID: 36709053
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
[TBL] [Abstract][Full Text] [Related]
8. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial.
Ali N; Lifford KJ; Carter B; McRonald F; Yadegarfar G; Baldwin DR; Weller D; Hansell DM; Duffy SW; Field JK; Brain K
BMJ Open; 2015 Jul; 5(7):e008254. PubMed ID: 26173719
[TBL] [Abstract][Full Text] [Related]
9. Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation.
Goodley P; Balata H; Alonso A; Brockelsby C; Conroy M; Cooper-Moss N; Craig C; Evison M; Hewitt K; Higgins C; Johnson W; Lyons J; Merchant Z; Rowlands A; Sharman A; Sinnott N; Sperrin M; Booton R; Crosbie PAJ
Thorax; 2023 Dec; 79(1):58-67. PubMed ID: 37586744
[TBL] [Abstract][Full Text] [Related]
10. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
11. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
12. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
14. Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial.
Crosbie PAJ; Gabe R; Simmonds I; Hancock N; Alexandris P; Kennedy M; Rogerson S; Baldwin D; Booton R; Bradley C; Darby M; Eckert C; Franks KN; Lindop J; Janes SM; Møller H; Murray RL; Neal RD; Quaife SL; Upperton S; Shinkins B; Tharmanathan P; Callister MEJ
Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35777775
[TBL] [Abstract][Full Text] [Related]
15. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Kitchener HC; Gittins M; Rivero-Arias O; Tsiachristas A; Cruickshank M; Gray A; Brabin L; Torgerson D; Crosbie EJ; Sargent A; Roberts C
Health Technol Assess; 2016 Sep; 20(68):1-138. PubMed ID: 27632816
[TBL] [Abstract][Full Text] [Related]
16. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
17. Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services.
Gilbert H; Sutton S; Morris R; Petersen I; Wu Q; Parrott S; Galton S; Kale D; Magee MS; Gardner L; Nazareth I
Health Technol Assess; 2017 Jan; 21(3):1-206. PubMed ID: 28121288
[TBL] [Abstract][Full Text] [Related]
18. Impact of messaging informed by behavioural science on uptake of targeted lung health checks: a service evaluation.
Salman M; Fernandez Crespo R; Judah G
Lancet; 2023 Nov; 402 Suppl 1():S82. PubMed ID: 37997128
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness and health impact of lung cancer screening with low-dose computed tomography for never smokers in Japan and the United States: a modelling study.
Kowada A
BMC Pulm Med; 2022 Jan; 22(1):19. PubMed ID: 34996423
[TBL] [Abstract][Full Text] [Related]
20. Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.
Taylor AH; Thompson TP; Streeter A; Chynoweth J; Snowsill T; Ingram W; Ussher M; Aveyard P; Murray RL; Harris T; Green C; Horrell J; Callaghan L; Greaves CJ; Price L; Cartwright L; Wilks J; Campbell S; Preece D; Creanor S
Health Technol Assess; 2023 Mar; 27(4):1-277. PubMed ID: 37022933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
